Works matching IS 14783223 AND DT 2023 AND VI 43 AND IP 6
Results: 24
Reply to: "Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank".
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1362, doi. 10.1111/liv.15598
- By:
- Publication type:
- Article
Overcoming the challenges of eliminating viral hepatitis in low‐ and middle‐income countries.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1365, doi. 10.1111/liv.15574
- By:
- Publication type:
- Article
Steatotic hepatocellular carcinoma: Association of MRI findings to underlying liver disease and clinicopathological characteristics.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1332, doi. 10.1111/liv.15589
- By:
- Publication type:
- Article
Behavioural activity pattern, genetic factors, and the risk of nonalcoholic fatty liver disease: A prospective study in the UK Biobank.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1287, doi. 10.1111/liv.15588
- By:
- Publication type:
- Article
Right and left liver lobe biopsies by minilaparoscopy reveal clinically significant sampling error in staging and grading of autoimmune hepatitis.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1269, doi. 10.1111/liv.15583
- By:
- Publication type:
- Article
Carvedilol, probably the β‐blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1154, doi. 10.1111/liv.15582
- By:
- Publication type:
- Article
Non‐tuberculous mycobacteriosis of the liver responsive to empiric therapy.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis‐related liver disease: A multi‐center study validated by liver biopsy.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1277, doi. 10.1111/liv.15572
- By:
- Publication type:
- Article
Hepatocytic ballooning in non‐alcoholic steatohepatitis: Dilemmas and future directions.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1170, doi. 10.1111/liv.15571
- By:
- Publication type:
- Article
Hepatitis C screening and detection program in a large population: Epidemiological transition and characterization of the disease.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1225, doi. 10.1111/liv.15570
- By:
- Publication type:
- Article
Low risk of viral hepatitis amongst patients with severe mental disorders.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1204, doi. 10.1111/liv.15569
- By:
- Publication type:
- Article
Toll‐like receptor 7 agonist, GS‐986, is an immune‐stimulant inducing follicular helper T cells and expanding HBs antigen‐specific B cells in vitro.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1213, doi. 10.1111/liv.15568
- By:
- Publication type:
- Article
Fatty liver disease at the basis of cardiac remodelling and increased heart rate: Insights from the UK Biobank.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1360, doi. 10.1111/liv.15567
- By:
- Publication type:
- Article
Association between antihypertensive drugs and hepatocellular carcinoma: A trans‐ancestry and drug‐target Mendelian randomization study.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1320, doi. 10.1111/liv.15566
- By:
- Publication type:
- Article
Novel urinary protein panels for the non‐invasive diagnosis of non‐alcoholic fatty liver disease and fibrosis stages.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1234, doi. 10.1111/liv.15565
- By:
- Publication type:
- Article
Carvedilol as the new non‐selective beta‐blocker of choice in patients with cirrhosis and portal hypertension.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1183, doi. 10.1111/liv.15559
- By:
- Publication type:
- Article
Spermidine suppresses the activation of hepatic stellate cells to cure liver fibrosis through autophagy activator MAP1S.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1307, doi. 10.1111/liv.15558
- By:
- Publication type:
- Article
Fatty liver disease, heart rate and cardiac remodelling: Evidence from the UK Biobank.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1247, doi. 10.1111/liv.15556
- By:
- Publication type:
- Article
Global treatment rate and barriers to direct‐acting antiviral therapy: A systematic review and meta‐analysis of 146 studies and 1 760 352 hepatitis C virus patients.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1195, doi. 10.1111/liv.15550
- By:
- Publication type:
- Article
Subclinical liver traits are associated with structural and hemodynamic brain imaging markers.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1256, doi. 10.1111/liv.15549
- By:
- Publication type:
- Article
Transcriptomics confirm the establishment of a liver‐immune dual‐humanized mouse model after transplantation of a single type of human bone marrow mesenchymal stem cell.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1345, doi. 10.1111/liv.15546
- By:
- Publication type:
- Article
Combination of GM CSF and carbapenem is superior to carbapenem monotherapy in difficult‐to‐treat spontaneous bacterial peritonitis: A randomized controlled trial.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1298, doi. 10.1111/liv.15534
- By:
- Publication type:
- Article
Future anti‐HDV treatment strategies, including those aimed at HBV functional cure.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1157, doi. 10.1111/liv.15387
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1149, doi. 10.1111/liv.15303
- Publication type:
- Article